Aclaris Therapeutics (ACRS) executive compensation, 2026 proxy

Neal Walker, Chief Executive Officer, was paid $3.4M in 2025, up 134% from $1.4M the year before.

Filed
April 23, 2026
Annual meeting
June 4, 2026
Pay year
2025
Named executives
3
CEO total pay
$3.4M+134% vs prior year
CEO pay in equity
71%$2.4M in awards
Prior say-on-pay support
76%of votes cast
CEO Target Bonus
60%Percentage of base salary
Say-on-Pay Support
76%Prior year advisory vote
CEO Base Salary
$615,000Increased 23% in 2025

How Walker was paid

$3.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary18%Stock awards25%Option awards47%Non-equity incentive10%

Named executive officers

ExecutiveTotal
Neal WalkerChief Executive Officer$3,375,591
Kevin BalthaserChief Financial Officer$1,490,790
James LoeropChief Business Officer$1,447,106

What changed and why

  • $3.4MCEO Neal Walker received total compensation of $3,375,591 in fiscal 2025 following his formal appointment as Chief Executive Officer.
  • 23%Dr. Walker's base salary increased by 23% to $615,000 in 2025 due to his transition from interim to permanent CEO.
  • 95%Named executive officers were awarded annual bonuses at 95% to 96% of their respective target levels based on performance achievement.
  • 76%Stockholders approved the 2024 say-on-pay proposal with approximately 76% support at the previous annual meeting.
  • Pearl Meyer served as the independent compensation consultant to advise on executive compensation design and peer benchmarking.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.